A detailed history of Assetmark, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Assetmark, Inc holds 132,020 shares of ABT stock, worth $15.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
132,020
Previous 118,497 11.41%
Holding current value
$15.2 Million
Previous $12.3 Million 22.24%
% of portfolio
0.04%
Previous 0.04%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$100.07 - $118.13 $1.35 Million - $1.6 Million
13,523 Added 11.41%
132,020 $15.1 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $621,000 - $693,192
6,165 Added 5.49%
118,497 $12.3 Million
Q1 2024

May 06, 2024

BUY
$109.52 - $120.96 $2.12 Million - $2.34 Million
19,371 Added 20.84%
112,332 $12.8 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $1.17 Million - $1.44 Million
13,015 Added 16.28%
92,961 $10.2 Million
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $809,616 - $971,404
8,475 Added 11.86%
79,946 $7.74 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $1.44 Million - $1.6 Million
14,278 Added 24.96%
71,471 $7.79 Million
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $712,792 - $838,999
7,359 Added 14.77%
57,193 $5.79 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $1.58 Million - $1.86 Million
16,648 Added 50.17%
49,834 $5.47 Million
Q3 2022

Nov 01, 2022

BUY
$96.76 - $112.03 $286,796 - $332,056
2,964 Added 9.81%
33,186 $3.21 Million
Q2 2022

Aug 03, 2022

BUY
$102.07 - $123.37 $924,345 - $1.12 Million
9,056 Added 42.79%
30,222 $3.28 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $1.23 Million - $1.5 Million
10,762 Added 103.44%
21,166 $2.51 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $733,384 - $897,988
6,348 Added 156.51%
10,404 $1.46 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $84,345 - $93,310
723 Added 21.69%
4,056 $479,000
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $17,878 - $21,045
169 Added 5.34%
3,333 $386,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $180,239 - $212,348
-1,656 Reduced 34.36%
3,164 $379,000
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $42,840 - $46,683
408 Added 9.25%
4,820 $528,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $113,816 - $138,222
1,242 Added 39.18%
4,412 $480,000
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $1.87 Million - $2.39 Million
-24,419 Reduced 88.51%
3,170 $290,000
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $1.57 Million - $2.3 Million
25,048 Added 985.75%
27,589 $2.18 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $27,635 - $30,764
352 Added 16.08%
2,541 $221,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $59,497 - $64,513
-727 Reduced 24.93%
2,189 $183,000
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $1,384 - $1,615
-19 Reduced 0.65%
2,916 $245,000
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $1,523 - $1,841
-23 Reduced 0.78%
2,935 $235,000
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $65,363 - $74,047
997 Added 50.84%
2,958 $214,000
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $12,222 - $14,745
-201 Reduced 9.3%
1,961 $144,000
Q2 2018

Aug 01, 2018

SELL
$57.57 - $63.54 $5,469 - $6,036
-95 Reduced 4.21%
2,162 $132,000
Q1 2018

May 16, 2018

SELL
$56.27 - $63.62 $74,163 - $83,851
-1,318 Reduced 36.87%
2,257 $135,000
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $4.9 Million - $5.25 Million
-91,335 Reduced 96.23%
3,575 $204,000
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $657,124 - $733,419
13,673 Added 16.83%
94,910 $5.06 Million
Q2 2017

Aug 15, 2017

BUY
N/A
67,619 Added 496.54%
81,237 $3.95 Million
Q1 2017

Sep 15, 2017

BUY
N/A
1,847 Added 15.69%
13,618 $605,000
Q4 2016

Sep 15, 2017

BUY
N/A
715 Added 6.47%
11,771 $452,000
Q3 2016

Sep 15, 2017

SELL
N/A
-24,768 Reduced 69.14%
11,056 $468,000
Q2 2016

Sep 15, 2017

BUY
N/A
2,086 Added 6.18%
35,824 $1.41 Million
Q1 2016

Sep 15, 2017

BUY
N/A
7,136 Added 26.83%
33,738 $1.41 Million
Q4 2015

Sep 15, 2017

BUY
N/A
26,602
26,602 $1.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.